← CYTOKINETICS INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net loss | — | ($127.8m) | ($106.3m) | ($121.7m) | ($127.3m) | ($215.3m) | ($389.0m) | ($526.2m) | ($589.5m) | ($785.0m) | — | |
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $16.5m | ($127.8m) | ($106.3m) | ($121.7m) | ($127.3m) | ($215.3m) | ($389.0m) | ($526.2m) | ($589.5m) | ($785.0m) | — | |
| Depreciation, Depletion and Amortization | $741k | $1.9m | $1.2m | $1.3m | $1.8m | $2.3m | $5.8m | $11.9m | $9.5m | $10.1m | $12.5m | |
| Depreciation | $700k | $1.9m | $1.2m | $1.3m | $1.8m | $2.3m | $5.8m | $11.9m | $9.5m | $10.1m | $12.5m | |
| Amortization of Debt Issuance Costs | — | — | — | — | $79k | $112k | — | — | — | — | — | |
| Depreciation of property and equipment | $741k | $1.9m | $1.2m | $1.3m | $1.8m | $2.3m | $5.8m | $11.9m | $9.5m | $10.1m | $12.5m | |
| Interest receivable and amortization on investments | — | $0 | ($1.7m) | ($2.6m) | ($1.2m) | $4.9m | ($4.7m) | ($15.7m) | ($32.5m) | ($16.0m) | — | |
| Deferred Income Tax Expense (Benefit) | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | |
| Share-based Payment Arrangement, Noncash Expense | $7.1m | $9.0m | $9.8m | $10.8m | $17.6m | $26.8m | $47.9m | $72.1m | $97.8m | $112.3m | $127.3m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | $9.6m | $10.5m | $19.6m | $2.5m | — | |
| Share-based Payment Arrangement, Expense | $7.1m | $9.0m | $9.8m | $10.8m | $17.6m | $26.8m | $47.9m | $72.1m | $97.8m | $112.3m | $127.3m | |
| Stock-based compensation expense | $7.1m | $9.0m | $9.8m | $10.8m | $17.6m | $26.8m | $47.9m | $72.1m | $97.8m | $112.3m | $127.3m | |
| Operating Lease, Impairment Loss | — | — | — | — | — | $2.8m | $0 | — | — | — | — | |
| Nonoperating Income (Expense) | $464k | $2.6m | $4.2m | $4.5m | $5.3m | $331k | $11.3m | $27.6m | $51.5m | $48.4m | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | — | $1.1m | $1.1m | $2.9m | ($743k) | $47.4m | ($56.7m) | $1.1m | $15.4m | $1.1m | ($16.0m) | |
| Accounts receivable | ($12k) | ($1.1m) | ($1.1m) | ($2.9m) | $743k | ($47.4m) | $56.7m | ($1.1m) | ($15.4m) | ($1.1m) | ($16.0m) | |
| Accounts payable | $1.7m | $1.5m | ($1.5m) | $4.4m | ($110k) | $1.1m | $4.5m | ($3.5m) | ($4.5m) | $2.7m | $7.8m | |
| Deferred revenue | $2.2m | $1.5m | ($6.5m) | $0 | $87.0m | $0 | ($87.0m) | $0 | $52.4m | ($50.8m) | — | |
| Accrued and other liabilities | $8.9m | $766k | ($2.1m) | ($2.2m) | $7.1m | $15.1m | $10.8m | $17.1m | $14.2m | $33.6m | — | |
| Prepaid and other assets | ($707k) | ($2.2m) | $1.8m | ($3.9m) | ($5.2m) | ($7.4m) | ($7.4m) | $1.6m | ($2.4m) | ($2.9m) | — | |
| Net Cash Provided by (Used in) Operating Activities | $37.0m |
($101.8m)
-375.16%
|
($101.2m)
+0.53%
|
($90.9m)
+10.18%
|
$8.9m
+109.84%
|
($142.5m)
-1693.67%
|
($299.5m)
-110.15%
|
($414.3m)
-38.33%
|
($395.9m)
+4.45%
|
($510.0m)
-28.83%
|
($555.5m)
-8.91%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $1.6m | $2.9m | $889k | $2.6m | $11.1m | $48.9m | $11.3m | $1.4m | $3.9m | $24.8m | ($25.3m) | |
| Gain (Loss) on Disposition of Property Plant Equipment | $18k | $67k | $0 | $0 | $0 | — | $0 | $0 | $45k | $0 | ($2.1m) | |
| Cash, Cash Equivalents, and Short-term Investments | $163.9m | $285.4m | $198.7m | $267.8m | $501.0m | $623.7m | $829.3m | $655.4m | $1.2b | $1.2b | — | |
| Gain (Loss) on Sale of Investments | — | — | — | — | $573k | $0 | ($107k) | ($35k) | — | — | — | |
| Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | — | — | — | — | $247.3m | $422.8m | $604.6m | $870.9m | $744.2m | $1.1b | — | |
| Purchases of investments | ($145.2m) | ($240.4m) | ($240.2m) | ($277.9m) | ($435.8m) | ($525.0m) | ($855.4m) | ($635.2m) | ($1.3b) | ($1.1b) | — | |
| Maturities of investments | — | — | $246.2m | $202.6m | $247.3m | $422.8m | $604.6m | $870.9m | $744.2m | $1.1b | — | |
| Sales of investments | — | — | $0 | $3.2m | $3.1m | $3.3m | $0 | $5.0m | $0 | $6.0m | — | |
| Net cash (used in) provided by investing activities | ($52.1m) | ($65.8m) | $5.1m | ($74.7m) | ($196.5m) | ($147.8m) | ($262.1m) | $239.3m | ($553.1m) | $16.7m | — | |
| Net Cash Provided by (Used in) Investing Activities | ($52.1m) | ($65.8m) | $5.1m | ($74.7m) | ($196.5m) | ($147.8m) | ($262.1m) | $239.3m | ($553.1m) | $16.7m | ($503.7m) | |
| Cash flows from financing activities: | ||||||||||||
| Repayments of Long-term Debt | — | — | — | — | — | — | $47.7m | — | $8.7m | $10.8m | ($414.3m) | |
| Gain (Loss) on Extinguishment of Debt | — | — | — | — | — | — | ($2.7m) | — | $0 | — | — | |
| Non-cash interest expense related to debt | — | — | $920k | $919k | $6.6m | $7.1m | $5.7m | $7.3m | $11.6m | $22.9m | — | |
| Debt conversion expense | — | — | — | — | — | — | — | $0 | $0 | $121.2m | — | |
| Repayment of convertible debt | — | — | — | — | $0 | $0 | ($140.3m) | $0 | $0 | ($402.5m) | — | |
| Proceeds from issuance of convertible debt, net | — | — | — | — | $0 | $0 | $523.6m | $0 | $0 | $729.5m | — | |
| Proceeds from Issuance of Common Stock | $0 | $112.2m | $0 | $36.2m | $0 | $0 | $0 | $164.2m | $656.8m | $0 | $760.1m | |
| Proceeds from issuance of common stock related to private placement, net of issuance costs | — | — | $0 | $0 | $36.2m | $15.1m | $0 | $0 | $50.0m | $0 | $760.1m | |
| Proceeds from issuance of common stock under equity incentive and stock purchase plans | — | — | $3.2m | $1.4m | $5.4m | $7.9m | $17.5m | $18.5m | $53.0m | $36.0m | $760.1m | |
| Issuance of common stock in connection with repurchase of convertible note | — | — | — | — | $0 | $0 | $317.1m | $0 | $0 | $107.9m | $760.1m | |
| Net Cash Provided by (Used in) Financing Activities | $16.9m |
$225.9m
+1237.43%
|
$13.1m
-94.19%
|
$159.8m
+1116.81%
|
$234.1m
+46.52%
|
$320.0m
+36.67%
|
$516.2m
+61.31%
|
$221.3m
-57.12%
|
$930.6m
+320.49%
|
$524.5m
-43.64%
|
$1.2b
+136.78%
|
|
| Net (decrease) increase in cash, cash equivalents, and restricted cash | — | $58.3m | ($83.0m) | ($5.8m) | $46.6m | $29.7m | ($45.5m) | $46.2m | ($18.2m) | $30.4m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | ($83.0m) | ($5.8m) | $46.6m | $29.7m | ($45.5m) | $46.2m | ($18.2m) | $30.4m | $259.2m | |
| Cash, cash equivalents, and restricted cash, beginning of period | — | $125.2m | $42.3m | $36.4m | $83.0m | $112.7m | $67.2m | $113.4m | $95.2m | $125.6m | — | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | $58.3m | ($83.0m) | ($5.8m) | $46.6m | $29.7m | $67.2m | $113.4m | $95.2m | $125.6m | $259.2m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | — | ($20k) | $209k | ($715k) | ($841k) | |
| Effect of exchange rate changes | — | — | — | — | — | — | — | ($20k) | $209k | ($715k) | ($841k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $1.9m | $2.1m | $2.9m | $4.1m | $9.6m | $9.2m | $15.2m | $10.3m | $26.0m | $22.9m | — | |
| Income Taxes Paid, Net | $1k | $1k | $1k | — | ($2.3m) | ($4.4m) | ($9.6m) | ($10.5m) | ($19.6m) | $0 | — | |
| Additional Financial Items | ||||||||||||
| Derivative, Gain (Loss) on Derivative, Net | — | — | — | — | — | — | — | — | $1.3m | $4.2m | — | |
| Equity Securities, FV-NI, Unrealized Gain (Loss) | — | — | — | $300k | — | — | — | — | — | — | — | |
| General and Administrative Expense | $27.8m | $36.5m | $31.3m | $39.6m | $52.8m | $96.8m | $178.0m | $173.6m | $215.3m | $284.3m | — | |
| Investment Income, Interest | $449k | — | — | $4.5m | $5.3m | $1.0m | $11.4m | — | — | — | — | |
| Operating Expenses | $87.7m | $126.8m | $120.4m | $125.7m | $149.8m | $256.7m | $418.8m | $503.7m | $554.7m | $700.3m | — | |
| Operating Lease, Expense | — | — | — | $5.1m | $5.7m | — | — | — | — | — | — | |
| Realized Investment Gains (Losses) | — | — | — | — | — | — | — | — | $19k | $25k | — | |
| Non-cash interest expense on liabilities related to revenue participation right purchase agreement | — | — | — | $20.7m | $22.8m | $13.0m | $31.9m | $29.5m | $48.9m | $58.4m | — | |
| Non-cash lease expense | — | — | — | $3.6m | $4.2m | $7.4m | $2.6m | $3.8m | $4.3m | $5.6m | — | |
| Change in fair value of derivative liabilities | — | — | — | — | — | — | $0 | $0 | ($1.3m) | ($4.2m) | — | |
| Change in fair value of liabilities related to RPI Transactions | — | — | — | — | — | — | $0 | $0 | $19.6m | $200k | — | |
| Realized (loss) gain on investment, net | — | — | — | — | — | — | $107k | $35k | ($19k) | ($25k) | — | |
| Operating lease liabilities | — | — | $0 | ($3.9m) | ($4.7m) | $43.5m | $1.7m | ($1.4m) | ($7.2m) | ($10.8m) | — | |
| Other non-current liabilities | — | — | — | $0 | $0 | $3.6m | ($4.1m) | ($9.6m) | ($1.4m) | ($6.2m) | — | |
| Investment in non-marketable equity security | — | — | — | — | — | — | — | $0 | $0 | ($5.0m) | — | |
| Repayment of finance lease liabilities | — | — | — | — | $0 | $0 | ($944k) | ($858k) | ($939k) | ($204k) | — | |
| Repayment of term loan | — | — | — | — | $0 | $0 | ($47.7m) | $0 | ($8.7m) | ($10.8m) | — | |
| Proceeds from draw on RPI Multi Tranche Loan | — | — | — | — | — | — | — | $50.0m | $200.0m | $175.0m | — | |
| Right-of-use assets recognized in exchange for operating lease obligations | — | — | $0 | $10.7m | $1.1m | $80.4m | $10.9m | $0 | $481k | $6.3m | — | |
| Right-of-use assets recognized in exchange for finance lease obligations | — | — | — | $0 | $0 | $1.3m | $1.1m | $0 | $0 | — | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.